These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Recurrent scleritis in lepromatous leprosy. Poon A, MacLean H, McKelvie P. Aust N Z J Ophthalmol; 1998 Feb; 26(1):51-5. PubMed ID: 9524032 [Abstract] [Full Text] [Related]
5. Bilateral iridocyclitis caused by Mycobacterium leprae diagnosed through paracentesis. Campos WR, Oréfice F, Sucena MA, Rodrigues CA. Indian J Lepr; 1998 Feb; 70(1):27-31. PubMed ID: 9598402 [Abstract] [Full Text] [Related]
6. Leprosy pseudoimbricata: an unusual presentation of steroid-modified borderline lepromatous leprosy. Kumar S, Mehta H, Aggarwal D, Chatterjee D, Narang T, Dogra S. Int J Dermatol; 2020 Apr; 59(4):e124-e125. PubMed ID: 31957882 [No Abstract] [Full Text] [Related]
17. Inoculation site leprosy in a tattoo as a paradoxical reaction following tuberculosis treatment. Branagan P, Moran B, Fitzgibbon M, Reid V, McMenamin M, Kane M, Kelly F, Barnes L, McLaughlin A, Keane J. Int J Tuberc Lung Dis; 2016 May; 20(5):706-8. PubMed ID: 27084829 [Abstract] [Full Text] [Related]
19. Presence of Mycobacterium leprae in epidermal cells of lepromatous skin and its significance. Satapathy J, Kar BR, Job CK. Indian J Dermatol Venereol Leprol; 2005 May; 71(4):267-9. PubMed ID: 16394437 [Abstract] [Full Text] [Related]
20. Transepidermal elimination of lepromatous granuloma: a mechanism for mass transport of viable bacilli. Namisato M, Kakuta M, Kawatsu K, Obara A, Izumi S, Ogawa H. Lepr Rev; 1997 Jun; 68(2):167-72. PubMed ID: 9217357 [Abstract] [Full Text] [Related] Page: [Next] [New Search]